Sofosbuvir-containing regimens are safe and effective in the treatment of HCV patients with moderate to severe renal impairment.
Eletreby R, El-Serafy M, Anees M, Kasem G, Salama M, Elkhouly R, Hamdy M, Abdel Haleem H, Kamal E, Abdel-Razek W, Salama R, Elshenawy M, Shafeek A, Hassany M, El-Sayed MH, El-Shazly Y, Esmat G.
Eletreby R, et al. Among authors: salama r, salama m.
Liver Int. 2020 Apr;40(4):797-805. doi: 10.1111/liv.14299. Epub 2019 Dec 20.
Liver Int. 2020.
PMID: 31858694